Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Hypothyroidism after Radiotherapy of Locally Advanced Head and Neck Cancer

국소 진행된 두경부암 환자의 방사선치료 후 갑상샘기능저하증

  • Lee, Jeong-Eun (Department of Radiation Oncology, Kyungpook National University School of Medicine) ;
  • Kim, Jae-Chul (Department of Radiation Oncology, Kyungpook National University School of Medicine) ;
  • Yea, Ji-Woon (Dongguk University Gyeongju Hospital) ;
  • Park, In-Kyu (Department of Radiation Oncology, Kyungpook National University School of Medicine)
  • 이정은 (경북대학교 의학전문대학원 방사선종양학교실) ;
  • 김재철 (경북대학교 의학전문대학원 방사선종양학교실) ;
  • 예지원 (동국대학교 경주병원 방사선종양학과) ;
  • 박인규 (경북대학교 의학전문대학원 방사선종양학교실)
  • Received : 2010.01.25
  • Accepted : 2010.04.22
  • Published : 2010.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of the present study was to retrospectively evaluate the incidence of hypothyroidism in locally advanced head and neck cancer patients who received radiotherapy (RT) either with or without neck dissection. Materials and Methods: From January 2000 to December 2005, 115 patients with locally advanced head and neck cancer and who received definitive RT or postoperative RT including standard anterior low-neck field were recruited to be part of this study. Nineteen patients had undergone ipsilateral neck dissection, whereas, 18 patients underwent bilateral neck dissection, and 78 patients were received RT alone. Patients' ages ranged from 28 to 85 years (median, 59 years) and there were a total of 73 male and 42 female patients. The primary tumor sites were the oral cavity, oropharynx, hypopharynx, larynx, and other sites in 18, 40, 28, 22 and 7 patients, respectively. Radiation dose to the thyroid gland ranged from 44 Gy to 66 Gy with a median dose of 50 Gy. Follow-up time ranged from 2 to 91 months, with a median of 29 months. Results: The 1- and 3- year incidence of hypothyroidism was 28.7% (33 patients) and 33.0% (38 patients), respectively. The median time to detection of hypothyroidism was 8.5 months (range, 0 to 36 months). A univariate analysis revealed that neck node dissection was a risk factor for hypothyroidism (p=0.037). However, no factor was statistically significant from the results of a multivariate analysis. Conclusion: Patients treated for advanced head and neck cancer with radiotherapy with or without neck dissection will develop hypothyroidism. It is important to check the thyroid function periodically in these patientsespecially with the risk factor of neck node dissection.

목 적: 국소 진행된 두경부암 환자에서 방사선치료를 포함한 근치적 치료 후 갑상샘기능저하증의 발생률을 분석하고자 후향적 연구를 실시하였다. 대상 및 방법: 2000년 1월부터 2005년 12월까지 본원에서 국소 진행된 두경부암으로 진단받고 근치적 목적으로 방사선치료 단독 또는 수술 후 방사선치료를 받은 환자 중 수술로 갑상샘을 절제하지 않았고, 방사선치료 전 갑상샘기능이 정상이며, 하부 경부림프절이 방사선치료 범위에 포함된 115명의 환자를 대상으로 본 연구를 시행하였다. 환자의 중앙연령은 59세(28~85세)이고 남자 73명, 여자 42명이었다. 원발병소의 위치는 구강, 구인두, 하인두, 후두, 그 외가 각각 18, 40, 28, 22, 7명이었으며, 편측 경부절제술을 받은 환자가 19명(16.5%), 양측 경부절제술을 받은 환자가 18명(15.7%), 방사선치료만을 시행한 환자가 78명(67.8%)이었다. 방사선치료는 6-MV X-ray를 사용하였으며, 통상 분할 조사법에 의해 하루 1.8~2 Gy 씩, 주 5회 조사하였다. 원발병소에 조사된 방사선량은 중앙값 70.2 Gy (59.4~79.4 Gy)이었으며, 하부 경부림프절에 조사된 방사선량은 중앙값 50.0 Gy (44.0~66.0 Gy)이었다. 추적관찰기간은 2~91개월이었으며, 중앙값은 29개월이었다. 결 과: 전체 115명 환자 중에서 38명(33.0%)의 환자에서 갑상샘기능저하증이 관찰되었다. 전체 환자의 1년, 3년의 갑상샘기능저하증 발생률은 각각 28.7% (33명), 33.0% (38명)이었으며, 갑상샘기능저하증 발생시기의 중앙값은 8.5개월(0~36개월)이다. 갑상샘기능저하증 발생에 영향을 주는 인자로 단변량분석결과 경부절제술 여부가 위험인자로 분석되었으나, 다변량분석에서는 통계적으로 유의한 관련 인자는 없었다. 결 론: 두경부 종양환자의 방사선치료를 포함한 근치적 치료 후 갑상샘기능저하증이 발생할 수 있으며, 대부분이 1년 이내 발생하므로 치료 후 갑상샘기능검사를 정기적으로 실시할 필요가 있다. 특히 경부 림프절제술 후 방사선 치료를 시행하는 경우 더욱 주의하여 갑상샘기능저하증의 발생을 확인해야 한다.

Keywords

References

  1. Leon X, Gras JR, Perez A, et al. Hypothyroidism in patients treated with total laryngectomy: a multivariate study. Eur Arch Otorhinolaryngol 2002;259:193-196 https://doi.org/10.1007/s00405-001-0418-x
  2. Gal RL, Gal TJ, Klotch DW, Cantor AB. Risk factors associated with hypothyroidism after laryngectomy. Otolaryngol Head Neck Surg 2000;123:211-217 https://doi.org/10.1067/mhn.2000.107528
  3. Sinard RJ, Tobin EJ, Mazzaferri EL, et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:652-657 https://doi.org/10.1001/archotol.126.5.652
  4. Aimoni C, Scanelli G, D'Agostino L, Pastore A. Thyroid function studies in patients with cancer of the larynx: preliminary evaluation. Otolaryngol Head Neck Surg 2003;129:733- 738
  5. Clemente C. Anatomy: a regional atlas of the human body. 2nd ed. Baltimore; Urban and Schwarzenberg, 1981:570-577
  6. Garcia-Serra A, Amdur RJ, Morris CG, Mazzaferri E, Mendenhall WM. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol 2005; 28:255-258 https://doi.org/10.1097/01.coc.0000145985.64640.ac
  7. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605 https://doi.org/10.1056/NEJM199108293250902
  8. Park IK, Kim JC. Hypothyroidism following surgery and radiation therapy for head and neck cancer. J Korean Soc Ther Radiol 1997;15:225-232
  9. Zohar Y, Tovim RB, Laurian N, Laurian L. Thyroid function following radiation and surgical therapy in head and neck malignancy. Head Neck Surg 1984;6:948-952 https://doi.org/10.1002/hed.2890060509
  10. Posner MR, Ervin TJ, Miller D, et al. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope 1984;94:451-454 https://doi.org/10.1288/00005537-198404000-00002
  11. Colevas AD, Read R, Thornhill J, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2001;51:599-604 https://doi.org/10.1016/S0360-3016(01)01688-1
  12. Weissler MC, Berry BW. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck 1991;13:420-423 https://doi.org/10.1002/hed.2880130508
  13. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-534 https://doi.org/10.1001/archinte.160.4.526
  14. Tami TA, Gomez P, Parker GS, Gupta MB, Frassica DA. Thyroid dysfunction after radiation therapy in head and neck cancer patients. Am J Otolaryngol 1992;13:357-362 https://doi.org/10.1016/0196-0709(92)90076-6
  15. Grande C. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol 1992;25:31-36 https://doi.org/10.1016/0167-8140(92)90192-W
  16. Tell R, Sjodin H, Lundell G, Lewin F, Lewensohn R. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1997;39:303-308
  17. Liening DA, Duncan NO, Blakeslee DB, Smith DB. Hypothyroidism following radiotherapy for head and neck cancer. Otolaryngol Head Neck Surg 1990;103:10-13 https://doi.org/10.1177/019459989010300102
  18. Koc M, Unuvar N, Sen RC, Capoglu I, Sen M. A prospective evaluation of early thyroid dysfunction on completion of neck radiotherapy. Oral Oncol 2003;39:597-600 https://doi.org/10.1016/S1368-8375(03)00046-0
  19. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991;119:733-737 https://doi.org/10.1016/S0022-3476(05)80288-4
  20. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31:1165-1170 https://doi.org/10.1016/0360-3016(95)00019-U
  21. Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA, et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol 2000;57:97-101 https://doi.org/10.1016/S0167-8140(00)00276-0
  22. Norris AA, Amdur RJ, Morris CG, Mendenhall WM. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol 2006;29:442-445 https://doi.org/10.1097/01.coc.0000217831.23820.85
  23. Koc M, Capoglu I. Thyroid dysfunction in patients treated with radiotherapy for neck. Am J Clin Oncol 2009;32:150-153 https://doi.org/10.1097/COC.0b013e3181845517
  24. Alkan S, Baylancicek S, Ciftcic M, Sozen E, Dadas B. Thyroid dysfunction after combined therapy for laryngeal cancer: a prospective study. Otolaryngol Head Neck Surg 2008;139:787-791 https://doi.org/10.1016/j.otohns.2008.09.011
  25. Turner SL, Tiver KW, Boyages SC. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1995;31:279-283 https://doi.org/10.1016/0360-3016(93)E0112-J
  26. Posner MR, Weichselbaum RR, Fitzgerald TJ, et al. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1985;11:1887-1893 https://doi.org/10.1016/0360-3016(85)90268-8
  27. Kuten A, Lubochitski R, Fishman G, Dale J, Stein ME. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol 1996;61:281-283 https://doi.org/10.1002/(SICI)1096-9098(199604)61:4<281::AID-JSO10>3.0.CO;2-9